+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats

Antimicrobial Agents & Chemotherapy 40(6): 1352-1359
Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats
Cats were experimentally inoculated parenterally with the ME49 strain of Toxoplasma gondii to characterize the efficacies of two different dosages of orally administered clindamycin hydrochloride in the treatment of ocular toxoplasmosis. Concentrations of clindamycin hydrochloride at levels previously suggested to be inhibitory to T. gondii replication in vitro were achieved in the serum and aqueous humor but not in the cerebrospinal fluid. Antibiotic therapy, initiated 7 days after inoculation, resulted in no significant difference in the morphometric severity of ocular posterior segment lesions compared with that in the control groups. Treatment appeared to blunt T. gondii-specific immunoglobulin M production but had no significant effect on immunoglobulin G titers. Paradoxically, clindamycin administration was associated with increased morbidity and mortality from hepatitis and interstitial pneumonia, which are characteristic of generalized toxoplasmosis. Serum tumor necrosis factor alpha activity was detected at moderate levels in all groups of cats and correlated with the severity of clinical disease. The results of the study suggest that clindamycin, when administered at this specific time interval following inoculation, does not ameliorate ocular lesions and has a detrimental effect on the clinical course of acute, experimental toxoplasmosis in cats. The factors responsible for and the relevance of this detrimental effect to naturally occurring toxoplasmosis in humans and pet cats were not clear from the study but may relate to an antibiotic-associated decrease in the antitoxoplasmic activity of phagocytic cells responsible for the control of T. gondii.

Accession: 002914950

PMID: 8726000

Download PDF Full Text: Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats

Related references

The effect of clindamycin on experimental toxoplasmosis in mice. Revista Medica de Chile 105(7): 433-435, 1977

The treatment of toxoplasmosis: the effect of spiramycin and clindamycin on experimental infection. Giornale di Malattie Infettive e Parassitarie 36(11): 1098-1102, 1984

Effect of clindamycin on acute and chronic toxoplasmosis in mice. Antimicrobial Agents and ChemoTherapy 5(6): 647-651, 1974

Effect of clindamycin in a model of acute murine toxoplasmosis. Clinical Microbiology and Infection 3(1): 89-94, 1997

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis. Antimicrobial Agents and ChemoTherapy 43(9): 2240-2244, 1999

Clindamycin effects on experimental ocular toxoplasmosis in the rabbit. Archives of Ophthalmology 92(3): 244-247, 1974

Treatment of acute toxoplasmosis with intravenous clindamycin. European Journal of Clinical Microbiology & Infectious Diseases 10(3): 193-195, 1991

Treatment of acute toxoplasmosis with oral clindamycin. European Journal of Clinical Microbiology & Infectious Diseases 10(3): 181-183, 1991

Tentative treatment of experimental toxoplasmosis in mice I Effect of pyrimethamine, TAO, proguanil, and TCI, TBr, and TJ on the course of acute toxoplasmosis in mice. Acta Parasitol Polon 20: 261-264, 1962

Prophylactic efficacy of recombinant IL-12, clindamycin alone or in combination against experimental reactivated toxoplasmosis. Journal of the Egyptian Society of Parasitology 31(3): 853-865, 2001